(Q37169356)

18 August 2017

Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis (English)

1 reference

18 August 2017

1 reference

1 reference

Bailin Liang

1

1 reference

18 August 2017

Zheng Song

2

1 reference

18 August 2017

Bin Wu

3

1 reference

18 August 2017

Debra Gardner

4

1 reference

18 August 2017

David Shealy

5

1 reference

18 August 2017

Xiao-Yu Song

6

1 reference

18 August 2017

Paul H Wooley

7

1 reference

18 August 2017

15 April 2009

1 reference

18 August 2017

Journal of Inflammation

1 reference

18 August 2017

6

1 reference

18 August 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1186/1476-9255-6-10

18 August 2017

0 references

cites work

Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673212

Interleukin-6 in the pathogenesis of rheumatoid arthritis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673212

Interleukin-6 inhibition and clinical efficacy in rheumatoid arthritis treatment--data from randomized clinical trials.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673212

Interleukin-6 and rheumatic diseases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673212

Interleukin-6 and chronic inflammation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673212

Interleukin-6: from basic science to medicine--40 years in immunology

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673212

Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673212

The role of the interleukin‐6 family of cytokines in inflammatory arthritis and bone turnover

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673212

A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673212

IL-6 in autoimmune disease and chronic inflammatory proliferative disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673212

IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673212

Interleukin 6 plays a key role in the development of antigen-induced arthritis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673212

Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673212

A novel monoclonal antibody screening method using the Luminex-100 microsphere system

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673212

Soluble IL-6 Receptor Governs IL-6 Activity in Experimental Arthritis: Blockade of Arthritis Severity by Soluble Glycoprotein 130

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19368720

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19368720

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19368720

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1476-9255-6-10

1 reference

Dimensions Publication ID

18 August 2017

0 references

1 reference

18 August 2017

1 reference